Skip to content
No picture yet

Procysbi 25 mg – DIN 02464705

Procysbi is Cysteamine Bitartrate 25 mg (capsule (delayed-release)), sold in Canada. It is used for cystinosis. It is supplied by Amgen Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Cysteamine Bitartrate 25 mg

Brand
Procysbi
Strength
25 mg
Used for
Cystinosis
Form
Capsule (delayed-release)
Manufacturer
Amgen Canada Inc
Drug class
Cystine depleting agent
Sold in
Canada
DIN
02464705

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Cysteamine Bitartrate pills and guides

What is Cysteamine Bitartrate used for?

Cysteamine Bitartrate is used for cystinosis.

Medicine type
Cystine depleting agent
Official uses from the US prescribing label

PROCYSBI is indicated for the treatment of nephropathic cystinosis in adults and pediatric patients 1 year of age and older.

From the FDA-approved label on DailyMed (published Jun 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02464705.
  • It names Procysbi, Cysteamine Bitartrate 25 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Procysbi also called mercaptamine bitartrate by Amgen Canada Inc.

In Canada: prescription only.

Ingredients

Active: Cysteamine (Cysteamine Bitartrate)

Other Cysteamine Bitartrate pills